Skip to main content
Top
Published in: Clinical Rheumatology 9/2012

01-09-2012 | Case Based Review

Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein

Authors: A. Laria, A. Zoli, M. Bocci, F. Castri, F. Federico, G. F. Ferraccioli

Published in: Clinical Rheumatology | Issue 9/2012

Login to get access

Abstract

Giant cell arteritis (GCA) is a vasculitis of large- vessels. A markedly elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are characteristics of GCA, although temporal artery biopsy remains the gold standard for the diagnosis. We describe a case of biopsy-proven GCA showing a heavy infiltration of CD68 macrophages and CD3 T cells and with normal ESR and CRP levels at diagnosis.
Key points
(1) GCA may occur with normal ESR in a percentage of about 4 to 15 % (although the American College of Rheumatology classification criteria for giant cell arteritis include an ESR of 50 mm/h or more), while it can occur with normal ESR and normal CRP in a percentage of about 0.8 %. So, the clinical suspicion must be confirmed with a positive biopsy.
(2) GCA patients with ESR >40 mm/h are characterized by higher incidence of headache and jaw claudication compared to patients with normal ESR. In our case, it occurred with normal ESR.
(3) Color duplex ultrasonography is a noninvasive, easy, and inexpensive method for supporting a diagnosis of TA, with a high sensitivity and specificity. It can predict which patient will need TAB.
Literature
1.
2.
go back to reference Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45:140CrossRef Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45:140CrossRef
3.
go back to reference Hunder GG (2006) The early history of giant cell arteritis and polymyalgia rheumatica. First descriptions to 1970. Mayo Clin Proc 81(8):1071–1083PubMedCrossRef Hunder GG (2006) The early history of giant cell arteritis and polymyalgia rheumatica. First descriptions to 1970. Mayo Clin Proc 81(8):1071–1083PubMedCrossRef
4.
go back to reference Hellmann DB (2004) Giant cell arteritis and polymyalgia rheumatica. In: Imboden JB, Hellmann DB, Stone JH (eds) Current rheumatology diagnosis and treatment. McGraw Hill, New York, pp 235–241 Hellmann DB (2004) Giant cell arteritis and polymyalgia rheumatica. In: Imboden JB, Hellmann DB, Stone JH (eds) Current rheumatology diagnosis and treatment. McGraw Hill, New York, pp 235–241
5.
go back to reference Hunder GG, Bloch DA, Michel BA, Stevens MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef Hunder GG, Bloch DA, Michel BA, Stevens MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef
6.
go back to reference Bhatti MT, Tabandeh H (2001) Giant cell arteritis: diagnosis and management. Curr Opin Ophthalmol 12:393–399PubMedCrossRef Bhatti MT, Tabandeh H (2001) Giant cell arteritis: diagnosis and management. Curr Opin Ophthalmol 12:393–399PubMedCrossRef
7.
go back to reference Ezeonyeji Amara N, Borg Frances A, Dasgupta Bhaskar (2011) Delays in recognition and management of giant cell arteritis:results from a retrospective audit. Clin Rheumatol 30:259–262PubMedCrossRef Ezeonyeji Amara N, Borg Frances A, Dasgupta Bhaskar (2011) Delays in recognition and management of giant cell arteritis:results from a retrospective audit. Clin Rheumatol 30:259–262PubMedCrossRef
8.
go back to reference Weyand CM, Goronzy JJ (2003) Giant cell arteritis and polymalgia rheumatic. Ann Intern Med 139:505–515PubMed Weyand CM, Goronzy JJ (2003) Giant cell arteritis and polymalgia rheumatic. Ann Intern Med 139:505–515PubMed
9.
go back to reference Hall JK, Volpe NJ, Galetta SL, Liu GT et al (2003) The role of unilateral temporal artery biopsy. Ophthalmology 110(3):543–548PubMedCrossRef Hall JK, Volpe NJ, Galetta SL, Liu GT et al (2003) The role of unilateral temporal artery biopsy. Ophthalmology 110(3):543–548PubMedCrossRef
10.
go back to reference Nesher G, Shemesh D, Mates M, Sonnenblick M, Abrmowitz HBJ (2002) The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. Rheumatol 29(6):1224–1226 Nesher G, Shemesh D, Mates M, Sonnenblick M, Abrmowitz HBJ (2002) The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. Rheumatol 29(6):1224–1226
11.
go back to reference Karahaliou M, Vaiopoulos G, Papaspyrou S, Kankis M, Revenas K, Sfikakis PP (2006) Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8(4):R116PubMedCrossRef Karahaliou M, Vaiopoulos G, Papaspyrou S, Kankis M, Revenas K, Sfikakis PP (2006) Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8(4):R116PubMedCrossRef
12.
go back to reference Habib Hisham M, Essa Ashraf A, Hassan Ayman A (2012) Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol 31:231–237PubMedCrossRef Habib Hisham M, Essa Ashraf A, Hassan Ayman A (2012) Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol 31:231–237PubMedCrossRef
13.
go back to reference Wong RL, Korn JH (1986) Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med 80(5):959–964PubMedCrossRef Wong RL, Korn JH (1986) Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med 80(5):959–964PubMedCrossRef
14.
go back to reference Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arterttis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168PubMedCrossRef Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arterttis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168PubMedCrossRef
15.
go back to reference Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR (1978) Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 88(2):162–167PubMed Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR (1978) Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 88(2):162–167PubMed
16.
go back to reference Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845PubMedCrossRef Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845PubMedCrossRef
17.
go back to reference Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ (2011) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41(6):866–871PubMedCrossRef Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ (2011) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41(6):866–871PubMedCrossRef
18.
go back to reference Weyand CM, Goronzy JJ (1999) Arterial wall injury in giant cell arteritis. Arthritis Rheum 42(5):844–853PubMedCrossRef Weyand CM, Goronzy JJ (1999) Arterial wall injury in giant cell arteritis. Arthritis Rheum 42(5):844–853PubMedCrossRef
19.
go back to reference Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Peña-Sagredo JL, Martin J, Gonzalez-Gay MA (2008) The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum 38:116–123PubMedCrossRef Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Peña-Sagredo JL, Martin J, Gonzalez-Gay MA (2008) The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum 38:116–123PubMedCrossRef
20.
go back to reference Cantini F, Salvarani C, Olivieri I (1998) Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med 128(10):873–874PubMed Cantini F, Salvarani C, Olivieri I (1998) Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med 128(10):873–874PubMed
21.
go back to reference Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812PubMed Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812PubMed
22.
go back to reference Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP (2002) Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 3:14–19PubMedCrossRef Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP (2002) Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 3:14–19PubMedCrossRef
23.
go back to reference Russell AI, Cunninghame GDS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13(1):137–147PubMedCrossRef Russell AI, Cunninghame GDS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13(1):137–147PubMedCrossRef
24.
go back to reference Ellis ME, Ralston S (1983) The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 42:168–170 Ellis ME, Ralston S (1983) The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 42:168–170
25.
go back to reference Branum G, Massey EW, Rice J (1987) Erythrocyte sedimentation rate in temporal arteritis. South Med J 80:1527–1528 Branum G, Massey EW, Rice J (1987) Erythrocyte sedimentation rate in temporal arteritis. South Med J 80:1527–1528
26.
go back to reference Kyle V, Cawston TE, Hazleman BL (1989) Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 48:667–671 Kyle V, Cawston TE, Hazleman BL (1989) Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 48:667–671
27.
go back to reference Jundt JW, Mock D (1991) Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 34(2):217–219 Jundt JW, Mock D (1991) Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 34(2):217–219
28.
go back to reference Wise CM, Agudelo CA, Chmelewski WL, McKnight KM (1991) Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 34:1571–1574 Wise CM, Agudelo CA, Chmelewski WL, McKnight KM (1991) Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 34:1571–1574
29.
go back to reference Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168 Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168
30.
go back to reference Olsson AT, Elling H, Elling P (1997) Frequency of a normal erythrocyte sedimentation rate in patients with active,untreated arteritis temporalis and polymyalgia rheumatica: comment on the articleby Helfgott and Kieval. Arthritis Rheum 40:191–3 Olsson AT, Elling H, Elling P (1997) Frequency of a normal erythrocyte sedimentation rate in patients with active,untreated arteritis temporalis and polymyalgia rheumatica: comment on the articleby Helfgott and Kieval. Arthritis Rheum 40:191–3
31.
go back to reference von Blotzheim SG, Borruat FX (1996) [Neuro-ophthalmological complications of Horton's disease]. Rev Med Suisse Romande 116:21–25 von Blotzheim SG, Borruat FX (1996) [Neuro-ophthalmological complications of Horton's disease]. Rev Med Suisse Romande 116:21–25
32.
go back to reference Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, Rodriguez-Valverde V (2000) Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 19:73–75 Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, Rodriguez-Valverde V (2000) Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 19:73–75
33.
go back to reference Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N (2009) Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 27:830–833 Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N (2009) Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 27:830–833
Metadata
Title
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein
Authors
A. Laria
A. Zoli
M. Bocci
F. Castri
F. Federico
G. F. Ferraccioli
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-2031-3

Other articles of this Issue 9/2012

Clinical Rheumatology 9/2012 Go to the issue

Letter to the Editor

Response to Schwerla

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.